Npros.com MLM and Home Based Business Newswire

Coway Q3 Revenue Rises 14% to 1.43 Trillion Won as Overseas Growth Hits Record Operating Profit

Fri, 06 Nov 2026 08:00:00 GMT

SEOUL, South Korea - November 6, 2026

Coway Co., Ltd. reported third-quarter 2026 revenue of 1.4261 trillion won on November 6, up 13.7 percent from a year earlier, and said operating profit rose 7.3 percent to a record 260.8 billion won as overseas subsidiaries and new product categories kept growth going at home and abroad.

"On top of strong demand for our environmental home appliances, the robust sales of our new product categories have enabled us to maintain a stable growth trajectory in both domestic and overseas markets," said Soontae Kim, chief financial officer. "By leveraging the ongoing net growth of our domestic rental accounts as well as the rapid progress of our overseas subsidiaries, we are set to secure both the top-line expansion and the overall profitability that will serve as the foundation for solidifying our mid-to-long-term growth."

Net profit for the quarter fell 36.6 percent to 111.5 billion won, with the decline tied mainly to foreign-exchange losses even as operating results strengthened.

In Korea, Coway said third-quarter revenue was 754.9 billion won, up 2.0 percent. Seasonal promotions supported sales of ice water purifiers, beds, and massage chairs, while new rental sales volume rose 7.3 percent and net rental account additions jumped 26.7 percent to 214,000. New summertime appliances, including food waste disposers and wall-mounted air conditioners, also helped the domestic result.

Overseas subsidiaries generated 591.8 billion won in revenue, up 26.2 percent. Malaysia remained the largest foreign unit at 428.0 billion won, up 21.5 percent. The United States subsidiary rose 45.8 percent to 83.9 billion won, Thailand rose 38.0 percent to 57.7 billion won, and Indonesia rose 21.8 percent to 16.0 billion won.

Coway, listed in Korea, sells water and air purifiers, bidets, and related home appliances through a rental and membership model and has been expanding its BEREX sleep and wellness line of mattresses and massage chairs across Malaysia, the United States, Thailand, China, Indonesia, Vietnam, and Europe.

REAL Brokerage Parent Posts $728 Million Q3 Revenue After REMAX Deal; GAAP Loss Widens on Acquisition Costs

Thu, 05 Nov 2026 08:00:00 GMT

MIAMI - November 5, 2026

Real REMAX Group Inc., the company formed when The Real Brokerage acquired RE/MAX Holdings and the successor listed in the Npros directory as REAL Brokerage, reported third-quarter 2026 revenue of $727.9 million on November 5, up 28 percent from $568.5 million a year earlier. The quarter was the first reporting period after the August 24 closing, so the results fold in REMAX operations from August 25 while the year-ago figures are Real alone.

On a pro forma basis assuming the deal had closed at the start of 2025, combined revenue would have been $770.0 million, up 20 percent from $641.8 million. GAAP net loss widened to $67.2 million, or $2.25 per diluted share, from a $0.3 million loss, or $0.02 per share, a year earlier. The operating loss of $72.0 million included $52.3 million of acquisition-related expenses and $26.4 million of accelerated stock-based compensation tied to post-deal employee terminations. Adjusted EBITDA rose 66 percent to $33.8 million from $20.4 million, and adjusted EBITDA margin expanded to 4.6 percent from 3.6 percent.

"The first two months since bringing together Real and REMAX have reinforced our belief in the tremendous opportunity ahead," said Tamir Poleg, chairman and chief executive officer. "We've moved quickly to simplify the organization, improve operating efficiency and lay the foundation for a stronger, more competitive platform. While the housing market remains challenging, we are focused on what we can control: providing an unmatched value proposition, executing our integration and delivering sustainable market share growth and margin expansion."

Jenna Rozenblat, president and chief integration officer, said the company has actioned more than $40 million in annualized gross cost savings in about two months, including roughly $28 million of annualized synergies that benefit adjusted EBITDA, and that the first phase of organizational restructuring is largely complete. Chief financial officer Ravi Jani said the 2027 outlook reflects the earnings potential of the combined company and that capital priorities are cash generation, disciplined allocation, and deleveraging.

On the Real brokerage side, agent count rose 21 percent to 36,610 at quarter-end and transaction sides rose 17 percent to 62,738. After quarter-end, attrition and proactive offboarding of agents with unpaid dues or expired licenses brought the Real agent count to about 36,200 as of November 3. Global REMAX agent count was 148,088, up 0.4 percent, with U.S. and Canada agents down 3 percent to 72,118 and agents outside those markets up 4 percent to 75,970.

The company ended September 30 with $102.5 million in cash and cash equivalents and $6.9 million in short-term investments, or $109.4 million combined. In connection with the acquisition it put in place a $550 million senior secured term loan and a $40 million revolving facility, then made a voluntary $25 million principal repayment that left $525 million of term loan outstanding. It also repurchased about 264,000 shares for $4.7 million in the quarter.

For the fourth quarter of 2026, Real REMAX Group guided revenue of $575 million to $625 million and adjusted EBITDA of $32 million to $38 million. For full-year 2027, it guided revenue of $2.6 billion to $2.8 billion and adjusted EBITDA of $175 million to $190 million, assuming a weaker U.S. existing-home sales and price environment and no further acquisitions.

Real REMAX Group trades under the ticker REAX and operates an owned Real-branded brokerage, the REMAX franchise network, and ancillary title, mortgage, and technology services across more than 120 countries.

Isagenix Tells Associates It Has Been Acquired by Shaklee; MLM Plan Expected to End

Thu, 05 Nov 2026 08:00:00 GMT

GILBERT, Ariz. - November 5, 2026

Isagenix chief executive officer Sharron Walsh told promoters on a November 5 Global Associates call that the company has been acquired by Shaklee Corporation, according to accounts of the call that circulated among field leaders the following day. Neither Isagenix nor Shaklee had issued an official public announcement as of November 6.

Field discussion of the deal has repeatedly described Shaklee as acquiring certain assets of Isagenix, leaving open questions about how the company's debt will be handled and whether former owners will retain any stake. Isagenix was sold in 2023 to an ad hoc group of investors while founders Jim and Kathy Coover kept a minority interest; whether that stake survives the Shaklee transaction is unclear.

Promoters said the Isagenix multilevel compensation plan is expected to end, with associates moving onto Shaklee's plan, and that some Isagenix products will be folded into the Shaklee lineup. Comments circulating after the call suggested top leaders may keep more of their existing income than lower-ranked associates, though company officials had not published transition terms.

Isagenix was founded in 2002 by John Anderson, Jim Coover, and Kathy Coover and sells nutrition and personal-care products through independent associates. Shaklee, whose multilevel sales model dates to 1956 and which has been led by chairman and chief executive Roger Barnett since 2004, markets nutrition, beauty, and household products through its own associate and customer base. Until an official release appears, financial terms of the acquisition and the detailed field-transition rules remain unconfirmed.

eXp Parent AGNT Q3 Revenue Rises 6% to $1.4 Billion as Agent Count Grows; Company Posts Net Loss

Thu, 05 Nov 2026 08:00:00 GMT

BELLINGHAM, Wash. - November 5, 2026

AGNT, Inc., the publicly traded parent of eXp Realty and formerly known as eXp World Holdings, reported third-quarter 2026 revenue of $1.4 billion on November 5, up 6 percent from $1.3 billion a year earlier, as agent count, transactions, and sales volume all rose in a still-difficult housing market. The company swung to a net loss as costs and investment outpaced the top-line gain.

Net loss was $4.3 million, or $0.03 per diluted share, compared with net income of $3.5 million, or $0.02 per share, in the third quarter of 2025. Adjusted EBITDA fell 3 percent to $17.1 million from $17.7 million. Operating expenses rose 7 percent to $87.9 million. Cash and cash equivalents ended the quarter at $111.4 million, nearly flat with $112.8 million a year earlier, and the company said it carried no debt.

"It is a privilege to lead AGNT into its next chapter as Chief Executive Officer. AGNT's third-quarter results reflect a business with more agents, and more productive agents, than a year ago, and a financial position that we believe leaves us well-positioned to lead the industry through challenging times," said Leo Pareja, chief executive officer. "Our results are driven by the simple belief that when we put agents first, the business gets stronger."

Jesse Hill, chief financial officer, said the company "grew the top line in a housing market that remains challenging" while managing the business with discipline and continuing to invest in agent tools. He pointed to international as the fastest-growing segment, with revenue up 27 percent and continued progress toward profitability, and said the balance sheet gives flexibility to invest where opportunity is greatest for agents and shareholders.

On the operating side, AGNT said agents and brokers on its platform rose 5 percent to 87,457 as of September 30. Third-quarter real estate sales transactions increased 8 percent to 131,546, and sales volume rose 10 percent to $59.3 billion. Global agent Net Promoter Score was 67, down from 75 a year earlier. Net cash provided by operating activities was $18.2 million, compared with $28.9 million a year ago, while adjusted operating cash flow was $41.5 million, down from $45.4 million.

The company distributed $8.4 million in cash dividends to shareholders in the period. It paid a third-quarter dividend of $0.05 per share on August 28, and on October 23 the board declared a fourth-quarter dividend of $0.05 per share, expected to be paid December 4 to stockholders of record on November 20.

For the fourth quarter of 2026, AGNT guided revenue of $1.0 billion to $1.2 billion, operating expenses of $93 million to $97 million, and adjusted EBITDA between a $7 million loss and break-even. For the full year, it guided revenue of $4.85 billion to $5.05 billion, operating expenses of $362 million to $367 million, and adjusted EBITDA of $40 million to $47 million.

AGNT is the parent of eXp Realty, the cloud-based real estate brokerage, along with NextHome, FrameVR.io, and SUCCESS Enterprises. eXp Realty remains the company's primary agent-facing brand in the Npros directory.

Nu Skin Q3 Revenue Falls 15% to $311 Million as Customers Drop 18%; Company Guides Soft Full Year

Thu, 05 Nov 2026 08:00:00 GMT

PROVO, Utah - November 5, 2026

Nu Skin Enterprises reported third-quarter 2026 revenue of $311.0 million on November 5, down 14.6 percent from $364.2 million a year earlier and within the company's prior guidance range, as customer and affiliate counts kept falling and the core beauty and wellness business remained under pressure.

Reported earnings were a loss of $0.02 per share, or $0.10 per share excluding organizational transition costs and other charges, compared with earnings of $0.34 per share in the third quarter of 2025. Adjusted operating margin fell to 3.7 percent from 5.9 percent. Gross margin dropped to 65.0 percent from 70.5 percent, which the company attributed mainly to a higher mix of lower-margin manufacturing revenue from its Rhyz platform; gross margin in the core Nu Skin business was 76.6 percent, down from 77.7 percent.

"Third quarter revenue came in within our guidance range as we continued executing on our strategic priorities amid a challenging operating environment," said Ryan Napierski, president and chief executive officer. "During the quarter, we held our Nu Skin LIVE global convention in Japan, where we were excited to gather with 12,000 of our sales leaders and preview our next anti-aging offerings focused on women's health. We continue to see adoption of our Prysm iO platform, including year-to-date growth in revenue from our flagship LifePak nutritional supplements. Looking ahead, we are focused on driving affiliate and customer engagement through the holiday season and anticipate sequential growth in the fourth quarter."

The company said it ended the quarter with 609,469 customers, down 18 percent; 116,449 paid affiliates, down 10 percent; and 26,995 sales leaders, down 13 percent. Selling expenses were 33.2 percent of revenue, down from 35.8 percent, while general and administrative expenses fell $10.9 million year over year to 30.2 percent of revenue as the company continued to cut its fixed-cost base.

By region, Americas revenue was $53.1 million, down 17.0 percent, or 15.9 percent in constant currency. Southeast Asia/Pacific fell 23.5 percent to $43.0 million. Mainland China declined 10.9 percent to $37.9 million, or 16.1 percent in local currency. Japan fell 13.3 percent to $38.6 million, or 6.5 percent in constant currency. Europe and Africa dropped 26.6 percent to $27.9 million. Hong Kong/Taiwan fell 19.1 percent to $25.7 million, and South Korea fell 30.7 percent to $24.4 million. Total Nu Skin brand revenue was $252.6 million, down 19.2 percent.

Rhyz manufacturing revenue rose 19.3 percent to $56.8 million, partly offsetting the core decline. Nu Skin said it has placed about 41,000 Prysm iO devices globally and completed 4.5 million scans through the end of the third quarter, and that a version 2.0 app update late in August roughly doubled scan-to-purchase conversion to 10 percent.

The company ended September 30 with $164.9 million in cash and cash equivalents and cut total debt to $203.7 million. It paid $2.9 million in dividends in the quarter and did not repurchase shares, leaving $137.3 million under its current authorization. Interest expense fell to $3.5 million from $4.1 million.

For the fourth quarter, Nu Skin projected revenue of $310 million to $340 million, including an expected 1 percent foreign-currency tailwind, and adjusted earnings of $0.11 to $0.21 per share. For the full year, it projected revenue of $1.26 billion to $1.29 billion, down 13 to 15 percent, and adjusted earnings of $0.55 to $0.65 per share. Reported full-year earnings are expected to be a loss of $5.08 to $4.98 per share, reflecting earlier non-cash goodwill impairment and deferred-tax valuation charges. Interim chief financial officer Chelsea Lantz said the company still expects about $5 million of remaining cash organizational transition costs in the fourth quarter tied to its East-West operating model, which are excluded from adjusted guidance.

Nu Skin markets personal care, nutrition, and anti-aging products through an affiliate channel in nearly 50 markets and owns the Rhyz ecosystem of manufacturing and related businesses.

Primerica Q3 Revenue Rises 7% to $902 Million on Record Investment Sales as Recruiting Falls 10%

Wed, 04 Nov 2026 08:00:00 GMT

DULUTH, Georgia - November 4, 2026

Primerica reported third-quarter 2026 revenue of $902 million on November 4, up 7 percent from a year earlier, as record sales in its investment business offset lower profits in term life insurance and continued declines in recruiting and licensing of its independent sales force.

Net income for the quarter ended September 30 rose 1 percent to $209 million, and earnings per diluted share increased 6 percent to $6.76. The results included a pre-tax remeasurement gain of $12 million tied to the company's annual actuarial assumption review, compared with a $23 million gain in the same quarter of 2025. Adjusted net operating income rose 2 percent to $209 million, or $6.77 per diluted share, up 7 percent. Return on stockholders' equity was 31.3 percent.

"In the third quarter, Primerica's financial performance underscored the consistency of our business fundamentals, driven by our unique operating model that is purpose-built to help middle-income families achieve financial security," said Glenn Williams, chief executive officer. "Stable earnings in our Term Life segment and record investment sales continue to drive earnings momentum."

The Investment and Savings Products segment again led growth. Sales of mutual funds, managed accounts, annuities and other investment products rose 19 percent to a record $4.4 billion, and client asset values climbed 10 percent to $139.6 billion, helped by favorable equity markets. Net inflows totaled $407 million. Adjusted operating revenue in the segment increased 19 percent to $378.0 million, and adjusted operating income before taxes rose 21 percent to $114.1 million.

Term life insurance, the company's traditional core, was weaker. Adjusted operating revenue in the segment was essentially flat at $461.6 million, and adjusted operating income before taxes fell 12 percent to $152.7 million from $172.7 million. Net premiums were consistent with a year earlier, while adjusted direct premiums rose 3 percent. Issued term life face amount fell 5 percent to $25.7 billion, and the number of life insurance policies issued dropped 7 percent to 73,813. The company said total term life face amount in force reached $969 billion.

Primerica's distribution metrics continued to soften. The life-licensed sales force stood at 147,058 representatives at quarter end, down 3 percent from 152,200 a year earlier. Recruits fell 10 percent to 90,818 from 101,156, and new life-licensed representatives dropped 14 percent to 10,722 from 12,482. Life productivity, which measures average monthly policies issued per licensed representative, held steady at 0.17.

The Corporate and Other Distributed Products segment posted adjusted operating revenue of $62.2 million, up 10 percent, and adjusted operating income of $5.3 million, up 41 percent. Closed U.S. mortgage volume brokered by the company was $142.6 million, compared with $143.4 million a year ago.

Total adjusted operating income before taxes across all segments rose 1 percent to $272.1 million.

Primerica returned $159 million to stockholders during the quarter, including $122 million in share repurchases and $37 million in dividends. Its board approved a dividend of $1.20 per share, payable December 14, 2026, to stockholders of record on November 20. The company estimated that Primerica Life Insurance Company's statutory risk-based capital ratio was approximately 445 percent as of September 30.

Primerica, based in Duluth, Georgia, sells term life insurance, investment products and other financial services to middle-income households in the United States and Canada through a sales force of independent licensed representatives. The company said it was the third-largest issuer of term life insurance in North America in 2025 and insured more than 5.5 million lives as of the end of that year. Its shares trade on the New York Stock Exchange under the symbol PRI.

Nature's Sunshine Q3 Sales Fall 9% to $116.6 Million on China Slump; Company Cuts 2026 Outlook

Wed, 04 Nov 2026 08:00:00 GMT

LEHI, Utah - November 4, 2026

Nature's Sunshine Products reported third-quarter 2026 net sales of $116.6 million on November 4, down 9 percent from $128.3 million a year earlier, and cut its full-year outlook after a steep decline in China and a slowdown in its fast-growing digital business left results well short of the company's own expectations.

Excluding currency effects, sales fell 7 percent for the quarter ended September 30. Net income attributable to common shareholders dropped to $1.9 million, or $0.11 per diluted share, from $5.3 million, or $0.30 per share, in the third quarter of 2025. Adjusted EBITDA fell to $11.1 million from $15.2 million, and operating income declined to $5.3 million, or 4.5 percent of sales, from $9.0 million, or 7.0 percent of sales.

"Our third-quarter results were disappointing and fell short of our expectations," said Ken Romanzi, chief executive officer of the Lehi-based herbal and nutritional supplement maker. "We faced several challenges in our business, particularly in China and in our Digital business. In China, operational disruptions have had a more significant impact on our consultant leadership base than we initially anticipated which we have already begun rebuilding."

Romanzi added that following "several quarters of exceptional growth" in the digital business, the company is continuing to invest in that part of its portfolio "to position it for the next phase of growth," and said the company's confidence in its long-term potential "remains strong."

Asia, the company's largest region, generated $55.1 million in sales, down 14.9 percent in dollars and 11.2 percent in local currencies. On the company's earnings call, executives said China accounted for the majority of that decline, with sales there down 52 percent in constant currency, and that they expect China to remain a headwind into 2027 as the consultant leadership base adapts to changes the company has made. Outside China, weakness in Taiwan was partly offset by growth in Japan.

North America sales fell 6.1 percent to $34.0 million. Executives said digital sales slipped 1 percent from a year earlier after several quarters of strong growth, as the company lapped the rapid expansion of its social commerce business, while North American direct selling trends remained soft. Autoship subscriptions represented 40 percent of digital sales, up from 30 percent a year ago. Europe was essentially flat at $22.1 million, up 0.9 percent in local currency, with executives citing 7 percent growth in Eastern Europe and saying a market launch in Germany remains on track. Latin America and Other rose 3.4 percent to $5.5 million.

Gross margin slipped to 72.9 percent from 73.3 percent, which the company attributed mainly to unfavorable foreign exchange. Volume incentives, the commissions paid to the company's independent consultants, rose to 32.0 percent of net sales from 30.7 percent, reflecting the timing of promotional incentives and market mix. Selling, general and administrative expenses fell to $42.3 million from $45.7 million on lower variable selling expenses and cost management, though they rose as a share of sales to 36.3 percent.

The company noted that, following its December 2025 purchase of the noncontrolling interests in its China business, no net income was attributable to NSP China in the third quarter, compared with $1.0 million, or $0.06 per diluted share, a year earlier.

Operating cash flow for the first nine months of 2026 was $9.7 million, compared with $25.4 million in the same period of 2025, while capital expenditures rose to $6.8 million from $4.1 million. Through September, Nature's Sunshine repurchased 345,000 shares for $6.1 million, an average of $17.66 per share, and it ended the quarter with $89.4 million in cash and no debt. Executives said $11.3 million remains under the current share repurchase authorization.

Citing a stronger U.S. dollar and the recent challenges in China, Nature's Sunshine lowered its full-year 2026 guidance. It now expects net sales of $460 million to $470 million, down from a previous range of $490 million to $500 million, and adjusted EBITDA of $44 million to $48 million, down from $48 million to $52 million. For the fourth quarter, the company expects gross margin in the low 72 percent range, slightly below the prior year.

Nature's Sunshine manufactures most of its own products and markets them through independent consultants and digital channels in more than 40 countries.

USANA Q3 Net Sales Fall 4% to $206 Million as Core Customers Slide; Company Trims 2026 Outlook

Tue, 03 Nov 2026 08:00:00 GMT

SALT LAKE CITY, Utah - November 3, 2026

USANA Health Sciences reported third-quarter 2026 net sales of $206 million on November 3, down 4 percent from $214 million a year earlier, and lowered its full-year outlook as gains at its Hiya children's health subsidiary failed to offset a shrinking customer base in its core direct-selling business.

The Salt Lake City nutrition company posted a net loss attributable to USANA of $5.6 million, or $0.30 per diluted share, for the quarter ended October 3, compared with a loss of $6.5 million, or $0.36 per share, in the third quarter of 2025. Adjusted results showed a loss of $0.11 per share, versus a loss of $0.15 a year ago. Adjusted EBITDA fell 13 percent to $12.1 million. Currency movements helped reported sales by about $4 million; excluding that benefit, consolidated sales fell 5.6 percent. Sales were also down 8 percent from the second quarter.

The core network marketing business, which USANA calls Core Nutritional, generated $171 million in sales, down 3 percent in dollars and 6 percent in constant currency. Active customers in that business fell 8 percent year over year to 356,000. Active Brand Partners slipped to 162,000 from 168,000, and active Preferred Customers dropped to 194,000 from 220,000.

Asia Pacific, which accounts for about two-thirds of company sales, brought in $138 million, down 4 percent. Greater China, USANA's largest market, produced $94 million, up 1.4 percent in dollars but lower in local currency, and its customer count fell 9 percent to 192,000. North Asia sales dropped 18 percent to $14 million. Southeast Asia Pacific was the bright spot, with sales up 2 percent to $30 million and active customers up 3 percent from the prior quarter. The Americas and Europe region fell 11 percent to $33 million, with 73,000 active customers.

Hiya, the subscription-based children's vitamin brand in which USANA holds a 78.8 percent stake, posted sales of $32 million, up 2 percent from a year ago and 12 percent from the second quarter. Active monthly subscribers rose 18 percent sequentially to 195,500 after the company stepped up marketing spending, a move that weighed on the segment's margins. Hiya's sales through Target and Amazon more than doubled from the second quarter. Rise Wellness, the protein bar and snack business, saw sales fall 45 percent to $4 million.

"As we continue our transformation to an omnichannel health and wellness company, our third quarter results were mixed, with meaningful improvement in some areas and results that fell short of our expectations in others," said Chairman and Chief Executive Officer Kevin Guest. He said rebuilding the Core Nutritional active customer base is the company's top priority and its single largest growth lever. USANA said it is changing its Brand Partner incentive plan to more directly reward growth in active customers, investing in digital marketing for the USANA brand, and preparing new products to begin rolling out in 2027.

USANA now expects 2026 consolidated net sales approaching $900 million, down from its earlier forecast of $910 million, and adjusted EBITDA of $77 million versus $80.5 million previously. Adjusted earnings guidance was cut to $0.55 per share from $0.76, and the company now projects a full-year net loss of $16 million, or $0.90 per share. Core Nutritional sales are forecast at $740 million, Hiya at $130 million, and Rise Wellness at $30 million.

The company also disclosed that it had overstated second-quarter adjusted EBITDA attributable to USANA. A $29.1 million Hiya goodwill impairment had been added back in full rather than net of the $6.2 million share belonging to Hiya's minority owners. The correction lowered second-quarter adjusted EBITDA to $21.7 million from $27.8 million and reduced the August outlook to $80.5 million from $86.7 million. USANA said the error affected only the non-GAAP measure and not its reported GAAP results.

USANA ended the quarter with $179 million in cash and no debt, generated $8 million in free cash flow during the quarter and $36 million year to date, and cut inventory 13 percent from the end of 2025. It did not buy back any shares in the quarter and has about $34 million left under its repurchase authorization. Shares fell about 10 percent in after-hours trading following the release.

USANA, founded in 1992, develops and manufactures nutritional supplements, functional foods, and personal care products sold through independent Brand Partners and Preferred Customers in 25 markets.

Herbalife Q3 Net Sales Rise 6% to $1.35 Billion on India Surge; Company Raises Full-Year Sales Outlook

Mon, 02 Nov 2026 08:00:00 GMT

LOS ANGELES, California - November 2, 2026

Herbalife reported third-quarter 2026 net sales of $1.35 billion on November 2, up 6.0 percent from $1.27 billion a year earlier and ahead of the company's own guidance range. It was the nutrition company's fifth consecutive quarter of year-over-year sales growth.

On a constant-currency basis, sales rose 7.6 percent, with foreign exchange trimming about 1.6 percentage points from reported growth. Herbalife said the gain came mainly from higher sales volume, and management said worldwide volume rose 8.6 percent during the quarter.

Asia Pacific again led the way. Sales in the region climbed 18.4 percent to $517.9 million, or 26.1 percent in local currencies, driven largely by India, where management said local-currency sales jumped 52 percent. Latin America rose 9.0 percent to $250.2 million. North America, Herbalife's home market, grew 1.7 percent to $267.5 million, its second straight quarter of year-over-year growth. EMEA fell 4.9 percent to $259.0 million, and China dropped 22.0 percent to $55.6 million, or 26.4 percent in local currency.

Net income attributable to Herbalife was $58.8 million, or $0.55 per diluted share, compared with $43.2 million, or $0.42 per share, in the third quarter of 2025. Adjusted earnings were $0.64 per share. Adjusted EBITDA came to $182.4 million, above the company's guidance of $160 million to $180 million, for a margin of 13.5 percent. Gross margin slipped to 77.3 percent from 77.7 percent, which the company attributed to sales mix and cost changes tied to self-manufacturing and sourcing, partly offset by price increases.

The company's April refinancing cut net interest expense by $19.1 million from a year earlier. Herbalife ended the quarter with $409.2 million in cash, about $2.0 billion in total debt and a net leverage ratio of 2.0 times, down from 2.2 times at the end of June. Operating cash flow reached $298.0 million for the first nine months of the year, up from $235.0 million. Herbalife said it will begin buying back stock in the fourth quarter under the $250 million, three-year repurchase program its board authorized in September. No shares were repurchased under that program during the third quarter.

For the full year, Herbalife raised its net sales outlook to growth of 4.9 to 5.9 percent on a reported basis. It kept its reported adjusted EBITDA guidance at $670 million to $690 million and raised the constant-currency figure to $700 million to $720 million. For the fourth quarter, the company expects reported net sales growth of 0.5 to 4.5 percent and adjusted EBITDA of $145 million to $165 million.

The results were the first released under new leadership. John DeSimone, previously chief financial officer, became interim CEO on November 1 following the departure of Stephan Gratziani, and Scott Schaefer moved into the CFO role on the same day, two months earlier than originally planned. A board committee working with an executive search firm is still looking for a permanent chief executive. "Our priorities are clear: disciplined execution, profitable growth, and a focused roadmap for our business opportunity and digital platforms with measurable success metrics," DeSimone said.

In its quarterly report filed the same day, Herbalife disclosed that it reached a confidential settlement on October 2 resolving its long-running lawsuit with former technology vendor Eastern Computer Exchange, an amount the company called not material. The filing also notes that a proposed California class action alleging that Herbalife misclassified distributors as independent contractors remains pending, and that the company does not believe a loss is probable in that case.

Herbalife, founded in 1980, sells weight-management and nutrition products through independent distributors in more than 90 markets.

Tastefully Simple to End Direct Sales Channel January 1, Moving Sellers to Affiliate-Only Model

Sat, 31 Oct 2026 08:00:00 GMT

ALEXANDRIA, Minnesota - October 31, 2026

Tastefully Simple will close its traditional direct sales channel at the end of the year, completing a two-year move away from the multilevel model the Minnesota food company was built on in 1995.

Founder and CEO Jill Blashack Strahan announced the decision on October 31 in a video posted to the company's official Facebook page. "Over a long time and period of debate, I've finally come to the conclusion that I need to meet the world where it is," she said. "As of January 1st, we will be ending our traditional direct sales channel."

After January 1, 2027, Tastefully Simple plans to focus on three channels: an affiliate-only selling program, wholesale operations and direct-to-consumer sales. The company's current sellers, known as TS Ambassadors, will become "Ambassador Affiliates" who earn what Strahan described as a special commission on sales made through a personalized shopping link. Ambassadors may also choose to become wholesalers. Under the timeline described in the announcement, the company's direct sales operations end on December 31, 2026.

The change finishes a restructuring that began in January 2025. At that time the company renamed its consultants TS Ambassadors and stopped allowing new sellers to sponsor or build teams, asking them instead to sell through shareable shopping links on social media or at in-person tasting events, while hosts kept earning rewards. A small group of longtime leaders, designated Diamond and Gold Ambassadors, was allowed to keep building first-line teams under that hybrid plan. Strahan said in late 2024 that the company had designed the model after months of deliberation and that it was meant to suit younger sellers looking for a flexible side income without leadership demands. The new plan removes the remaining team-building element.

Tastefully Simple already runs a separate affiliate marketing program on its website aimed at content creators, bloggers and coupon sites. That program is free to join, has no sales minimums and pays commission on purchases made through an affiliate's unique link within a 30-day referral window. The company's seasonings, dip mixes, bread mixes and sauces are also sold through large retailers including Walmart and Amazon.

The company has previously cut staff and streamlined operations at its Alexandria headquarters. It has not released sales figures or said how many ambassadors are affected by the change, and no further details on commission rates for Ambassador Affiliates had been published as of November 2.

Tastefully Simple was founded by Strahan in Alexandria, Minnesota, and sells easy-prep foods such as Bountiful Beer Bread Mix, Onion Onion seasoning and Bacon Bacon through home tasting parties and online. It joins a growing list of party-plan and direct sales companies that have dropped multilevel compensation in favor of affiliate or direct-to-consumer models.

Real REMAX Group Agent Survey: Higher Mortgage Rates Push Buyers to the Sidelines as Agent Optimism Slips

Fri, 30 Oct 2026 08:00:00 GMT

MIAMI, Florida - October 30, 2026

Real REMAX Group, the real estate platform formed from the combination of The Real Brokerage and REMAX, says the agents in its network are seeing a housing market increasingly tilted toward buyers, but one where high mortgage rates are keeping many of those buyers on the sidelines. The findings come from the company's September 2026 Agent Survey, released October 30.

The survey drew responses from 177 real estate agents affiliated with The Real Brokerage Inc. across the United States and Canada, and was conducted between October 1 and October 9, 2026. The company said the results are meant to capture industry-level conditions and are not an indication of its own company-specific growth or transaction volume.

The company's Agent Optimism Index, which measures agents' 12-month outlook, fell to 45.8 in September from 54.3 in August, dropping below the 50 mark that signals a net positive view. Twenty-seven percent of agents said they felt more optimistic than the prior month, while 39 percent said they felt more pessimistic. Real REMAX Group's Transaction Growth Index, which tracks home sales activity agents report in their local markets, slipped to 40.3 from 44.6. More than half of agents, 52 percent, reported fewer transactions than in September 2025, while 29 percent reported no change and 19 percent reported an increase.

Fifty-five percent of agents described their local market as favoring buyers, up from 46 percent in August. Only 11 percent described seller-favorable conditions, down from 19 percent, and 34 percent called their markets balanced. Sixty-seven percent named mortgage rates and affordability as the biggest challenge facing buyers, up from 58 percent a month earlier, followed by economic uncertainty at 22 percent and inventory constraints at just 6 percent. The company said both the buyer-favorable reading and the affordability reading were the highest since its survey began.

Asked how higher rates are changing behavior, 66 percent of agents said buyers are pausing or delaying their home searches, 44 percent said buyers are becoming more selective or negotiating harder, and 26 percent said buyers are lowering their target prices. On the selling side, 39 percent said prospective sellers are delaying plans to list, 35 percent reported more willingness among sellers to cut asking prices, and 34 percent said sellers are more willing to offer concessions.

Looking ahead, nearly two-thirds of agents, 65 percent, said 30-year mortgage rates would have to fall below 6 percent to meaningfully stimulate demand, including 37 percent who said rates would need to fall below 5.5 percent. If rates stay above 7 percent through 2027, roughly half of agents expect home sales to decline compared with 2026 and 36 percent expect activity to stay flat, while nearly 60 percent anticipate lower home prices, including 33 percent who expect declines of more than 5 percent.

"Higher mortgage rates are putting renewed pressure on an already challenging housing market," said Tamir Poleg, Chairman and CEO of Real REMAX Group. "Buyers have more negotiating leverage today, but affordability remains a significant obstacle, causing many to delay their home searches. Agents are also seeing sellers reconsider their plans or become more flexible on pricing. Looking ahead, the survey suggests that a sustained recovery in housing activity will depend heavily on meaningful relief in mortgage rates."

For a brokerage whose agents earn through transaction commissions and whose model also rewards agents for attracting other agents to the platform, a slower market translates directly into pressure on agent income. Real REMAX Group, which trades on Nasdaq under the ticker REAX, says it supports more than 180,000 agents, more than 100,000 of them in the U.S. and Canada, with a presence in more than 120 countries and territories. The full survey summary is posted on the company's investor relations website.

DXN Holdings Q2 Net Profit Jumps 30 Percent to RM91.3 Million on Peru and Bolivia Sales; Declares 1-Sen Dividend

Thu, 29 Oct 2026 08:00:00 GMT

KUALA LUMPUR, Malaysia - October 29, 2026

DXN Holdings Bhd., the Malaysian health and wellness direct selling company best known for its Ganoderma mushroom coffees and supplements, said its net profit rose nearly 30 percent in its fiscal second quarter as stronger sales in Latin America and India offset softness elsewhere in its network.

In unaudited results filed with Bursa Malaysia on October 29, DXN reported net profit attributable to shareholders of RM91.29 million for the three months ended August 31, 2026, the second quarter of its financial year ending February 28, 2027. That compared with RM70.26 million in the same quarter a year earlier, an increase of 29.9 percent. Earnings per share rose to 1.85 sen from 1.41 sen.

Revenue for the quarter increased 5.3 percent to RM506.81 million from RM481.20 million. Pretax profit climbed to RM134.89 million from RM119.14 million, and earnings before interest, taxes, depreciation and amortization rose 11.3 percent to about RM151.3 million, lifting the EBITDA margin to 29.9 percent.

The company said growth came from continued momentum and active member engagement in Peru and Bolivia, where sales rose 13.7 percent and 49.3 percent from a year earlier, respectively. Sales in India grew 10.7 percent.

The quarter also marked a sharp rebound from a weak start to the year. Revenue rose 14.4 percent from the first quarter and net profit attributable to shareholders was up 56 percent sequentially. In a results review published October 30, RHB Research said Bolivia's growth was partly helped by currency appreciation, and that sequential gains in Peru and Bolivia benefited from members buying ahead of price revisions scheduled for the third quarter. The brokerage also pointed to lower foreign exchange losses of RM0.8 million, down from RM6.5 million a year earlier, savings of about RM6.5 million after DXN ended an aircraft charter arrangement in May 2026, and a lower effective tax rate of 30 percent compared with 38.3 percent.

The first half of the year was flatter. For the six months ended August 31, DXN's revenue slipped 1.1 percent to RM949.84 million from RM960.26 million, which the company attributed to slower sales in Morocco and lower export sales to the Middle East that offset gains in other markets. Six-month net profit attributable to shareholders rose 3.9 percent to RM149.82 million from RM144.17 million.

DXN's board declared a second interim single-tier dividend of 1.00 sen per share for the financial year, compared with 0.80 sen for the same quarter last year. The shares go ex-dividend on November 12, with an entitlement date of November 13 and payment on November 27, 2026. Dividends declared for the first half total 1.60 sen per share, compared with 1.70 sen a year earlier.

Looking ahead, DXN said it expects revenue and profit to keep growing, supported by three structural drivers: expansion of its upstream cultivation capacity, a wider midstream manufacturing footprint, and a resilient base of downstream consumers. The company acknowledged it faces challenges in some regions but said the breadth of its global operations and its integrated farm-to-consumer model give it confidence in its growth prospects.

In a separate filing the same day, DXN updated investors on several memorandums of understanding tied to its expansion. It said its proposed investment agreement in Morocco remains under review by Moroccan authorities, and that it is working with Brazil's health regulator, ANVISA, with help from the Brazilian Trade and Investment Promotion Agency, to clarify the approval pathway for registering and selling Ganoderma as a novel food ingredient in Brazil. It reported no material development on a separate memorandum with Invest Kedah Berhad.

DXN, founded in Malaysia in 1993 and listed on the Main Market of Bursa Malaysia, sells its products through a global network of members across Asia, Latin America, Africa, Europe and the Middle East.

Amorepacific Q3 Operating Profit Rises 25 Percent to 115.2 Billion Won as Net Income Falls 14 Percent

Thu, 29 Oct 2026 08:00:00 GMT

SEOUL, South Korea - October 29, 2026

Amorepacific Corp., South Korea's leading cosmetics company, said Thursday that its third-quarter operating profit rose 25.4 percent from a year earlier to 115.2 billion won, as stronger brands at home and fast growth in the Americas, Japan and India lifted results.

Revenue for the three months ended September 30 climbed 11.1 percent to 1.1295 trillion won, according to preliminary figures the company disclosed on October 29. The operating profit result was essentially in line with the market consensus of about 114.9 billion won, and the company's operating margin stayed above 10 percent for the third straight quarter.

Net profit moved the other way. Amorepacific said quarterly net income fell 14.3 percent to 58.5 billion won from 68.2 billion won a year earlier, which it attributed to non-operating costs. The company did not immediately provide details on those costs. For the first nine months of 2026, net income rose 17.8 percent to 264.84 billion won.

At the group level, Amorepacific Group reported consolidated third-quarter revenue of 1.2073 trillion won, up 8.9 percent, and operating profit of 130.1 billion won, up 24.7 percent. The group's operating margin improved 1.4 percentage points to 10.8 percent, and the company said group sales have now grown for nine consecutive quarters.

The domestic business led the improvement. Amorepacific's Korean revenue rose 11 percent to 620.5 billion won, while domestic operating profit jumped 42 percent to 84.6 billion won. The company credited strong sales of Sulwhasoo, Hera, Aestura and Illiyoon, along with double-digit growth in e-commerce, multi-brand shops and duty-free stores, the last helped by more tourists visiting Korea.

Overseas revenue increased 12 percent to 495.5 billion won, and overseas operating profit rose 14 percent to 48.5 billion won. In the Americas, Aestura more than doubled its sales on expanded distribution through Sephora and Amazon, and Innisfree grew more than 50 percent. In Japan, Aestura and COSRX each more than doubled sales, Hera grew more than 90 percent, and COSRX entered about 2,900 new local stores. Sales in India rose more than 60 percent on growth from Laneige, the arrival of Mamonde and a wider distribution network. In Europe, the Middle East and Africa, COSRX sales rose more than 30 percent and its U.K. TikTok Shop sales jumped more than 200 percent.

Not every part of the group grew. Combined sales at the beauty affiliates Innisfree, Etude, espoir and Amos Professional fell 12 percent to 103.2 billion won, and their operating profit dropped 29 percent to 5.2 billion won. The company tied that decline to ongoing restructuring, including streamlining of distribution channels.

Amorepacific said it plans to keep growing multiple brands together in overseas markets. The company reiterated its long-term goal of reaching 15 trillion won in annual sales by 2035, nearly triple the 4.25 trillion won it recorded in 2025, with a focus on North America, Europe, China, India and the Middle East, and Japan and Southeast Asia, and on expanding derma beauty, clinical skincare and hair care.

Amorepacific shares closed at 124,400 won on October 29, down 0.08 percent from the previous session.

Nature's Sunshine Recalls Andrographis Supplement in Australia Over Anaphylaxis Risk

Wed, 28 Oct 2026 08:00:00 GMT

CANBERRA, Australia - October 28, 2026

Nature's Sunshine Products has begun a consumer-level recall of its Andrographis herbal supplement in Australia, joining a growing list of companies pulling products that contain the herb after the country's medicines regulator concluded that the risk of severe allergic reactions could no longer be managed with warning labels.

The recall, recorded by the Therapeutic Goods Administration (TGA) as action RC-2026-RN-00869-1, began on October 28, 2026. It covers Nature's Sunshine Andrographis, listed on the Australian Register of Therapeutic Goods as AUST L 302367. The TGA classifies the action as a Class I recall at the consumer level, the most serious hazard category the agency uses. The responsible entity is Nature's Sunshine Products of Australia Pty Ltd, the Australian arm of the Lehi, Utah-based direct selling company. The recall record identifies batch 2212, with an expiry date of October 2028, while the TGA's consolidated Andrographis recall list, updated October 30, describes the action as covering all unexpired batches of the product.

Andrographis paniculata is an herb long sold in immune-support and cold-and-flu formulas. Since 2019, listed medicines in Australia containing the ingredient have been required to carry a label warning about the risk of allergic reactions, including anaphylaxis. According to the TGA, reports of anaphylaxis linked to Andrographis products continued at a sustained high level despite those warnings, including a fatal case reported in June 2024.

After publishing an updated safety review and supplementary report in April 2026 and taking public submissions, the TGA removed Andrographis from the list of ingredients permitted in low-risk listed medicines, effective September 17, 2026. The change barred new Andrographis products from being listed, but did not automatically remove products already on the market. Instead, the regulator asked sponsors to voluntarily cancel their listings or recall their products, and said it would begin taking regulatory action, including possible compulsory recalls or cancellations, from mid-October 2026 for companies that did not act.

Nature's Sunshine is the latest in a long line of sponsors to respond. The TGA's recall list now includes more than 30 Andrographis-containing products from more than 20 sponsors, including well-known supplement brands and pharmacy private labels, ranging from immune-support capsules to cold-and-flu tablets.

The TGA is advising consumers who have the Nature's Sunshine product not to use it. Customers can return it to the place of purchase or contact Nature's Sunshine customer service on 1800 687 577 to arrange a return and refund. Wholesalers have been told to inspect their stock immediately and quarantine all Andrographis product on hand. The agency notes that Andrographis reactions are unpredictable, can occur the first time a person takes the herb or after earlier use without problems, and often happen within 30 minutes. Anyone who may be experiencing anaphylaxis should call 000 immediately.

The recall is limited to the Australian market and to a single product. Nature's Sunshine Products, Inc., which trades on Nasdaq under the symbol NATR, sells herbal supplements, vitamins and personal care products through independent distributors and online channels in markets around the world. The company is scheduled to report its third quarter 2026 results on November 4.

Arbonne Hit With Second California Prop 65 Notice in Two Weeks, This Time Over Lead in Shakes and Greens

Wed, 28 Oct 2026 08:00:00 GMT

SAN DIEGO, California - October 28, 2026

Arbonne International has been served with a second California Proposition 65 notice in just over two weeks, this one alleging that two more of its protein shakes and two of its greens and wellness drink products expose consumers to lead without the warnings state law requires.

The 60-day notice of violation, dated October 28, 2026, was sent by Environmental Research Center, Inc. (ERC), a San Diego-based nonprofit that brings private enforcement actions under California's Safe Drinking Water and Toxic Enforcement Act of 1986. The notice was mailed by certified mail to Arbonne International, LLC at its Irvine, California, and Greenwood, Indiana, addresses and to its registered agents, and was filed with the California Attorney General's Proposition 65 reporting system the same day.

The notice names four products as examples: FeelFit Pea Protein Shake Simply1 Vanilla Flavor, EssentialMeal Meal Replacement Protein Shake Vanilla Flavor, Arbonne GreenSynergy Elixir Citrus Flavor and Arbonne BeWell Superfood Greens Spirulina. ERC alleges that each contains lead. The group says the list "includes, but is not limited to" those items and that it may continue to investigate other products, which could result in further notices.

The filing follows an October 13 notice from the same organization that targeted four other Arbonne shake flavors, alleging lead in FeelFit Simply1 Chocolate, FeelFit Vanilla and EssentialMeal Coffee and both lead and cadmium in EssentialMeal Chocolate. The new notice extends the dispute beyond the shake line to Arbonne's GreenSynergy and BeWell greens products.

Proposition 65 requires businesses to give a clear and reasonable warning before exposing California consumers to chemicals the state lists as causing cancer, birth defects or other reproductive harm. California listed lead as a developmental and reproductive toxicant in 1987 and as a carcinogen in 1992. According to the notice, the exposure comes from ingesting the products as directed, and the alleged violations have occurred every day since at least October 28, 2023.

ERC says it intends to file a private enforcement lawsuit in the public interest 60 days after the notice is effectively served, unless a public prosecutor first files and diligently pursues its own action. The group says it would prefer to resolve the matter through an enforceable written agreement under which Arbonne would reformulate the products or add warning labels, pay a civil penalty, and provide compliant warnings to California customers who bought the products in the past three years. A certificate of merit signed by ERC's in-house counsel states that he consulted with experts and believes there is a reasonable and meritorious case for a private action.

A Proposition 65 notice is an allegation, not a finding of wrongdoing, and no lawsuit had been filed as of the notice date. The notice does not announce a recall or claim that the products are unsafe at the levels found. It alleges only that required warnings are missing. Under the statute, civil penalties can reach $2,500 per violation per day.

Arbonne, headquartered in Irvine, California, sells plant-based skin care, cosmetics and nutrition products, including its FeelFit, EssentialMeal, GreenSynergy and BeWell lines, through a network of independent consultants.

Natural Health Trends Q3 Revenue Falls 20% to $7.6 Million as Discounts Steady Member Count

Wed, 28 Oct 2026 08:00:00 GMT

LOS ANGELES, California - October 28, 2026

Natural Health Trends Corp., the publicly traded direct-selling company behind the NHT Global brand, reported third-quarter revenue of $7.6 million on Wednesday, a 20 percent drop from the same quarter a year ago, as it leaned on discounts and cheaper product packages to hold on to members in a difficult main market.

For the three months ended September 30, 2026, net sales came to $7.56 million, compared with $9.48 million in the third quarter of 2025 and essentially flat with the $7.6 million it booked in the second quarter of this year. The company posted an operating loss of $277,000, narrower than the $643,000 loss in the second quarter and the $495,000 loss a year earlier. Net loss was $232,000, or 3 cents per diluted share, compared with a loss of $431,000, or 4 cents per share, in the year-ago quarter.

Commissions paid to members fell to $2.71 million from $3.88 million a year earlier, and selling, general and administrative expenses dropped to $3.17 million from $3.61 million. Gross profit was $5.61 million, down from $6.99 million.

The company counted 27,040 Active Members at the end of September, which it defines as people who placed at least one product order in the previous 12 months. That was up from 26,000 at the end of June and 26,650 at the end of 2025, but still below the 28,030 it reported a year earlier.

For the first nine months of 2026, revenue was $24.4 million, down 19 percent from $30.0 million in the same period of 2025. The year-to-date operating loss widened to $1.4 million from $1.2 million, and the net loss grew to $837,000 from $294,000.

President Chris Sharng blamed the decline on consumer pessimism in the company's largest market, regulatory uncertainty, and what he called previously reported member code of conduct matters, all of which he said continued to weigh on purchasing and member activity. In response, the company introduced additional incentives and lower-priced packages. Sharng said those moves accounted for most of the year-over-year revenue decline, but argued they made products more accessible and helped lift the Active Member count and steady sales late in the quarter.

Sharng also pointed to the company's 25th anniversary celebration in Hong Kong in August, which he said drew 1,000 attendees, the launch of a new AI-powered marketing and communication app, and appreciation events in three key markets. He said ongoing restructuring to protect margins and cut costs drove the 57 percent reduction in operating loss from the prior quarter, while acknowledging that conditions remain challenging.

The balance sheet continued to shrink. Cash, cash equivalents and marketable securities totaled $17.6 million at September 30, down from $28.9 million at the end of 2025. The company attributed the drop mainly to stock buybacks and dividends, along with cash used in operations. Net cash used in operating activities was $3.3 million for the first nine months, compared with $5.0 million a year earlier. Deferred revenue fell to about $3.0 million from $5.6 million at year-end, and amounts held in member eWallets declined to $2.4 million from $2.8 million.

Natural Health Trends spent $5.9 million repurchasing stock during the first nine months of the year, and its weighted average share count for the quarter fell to about 8.6 million from 11.5 million a year earlier. It bought back 28,022 shares on the open market for $27,000 during the third quarter and another 57,269 shares for $56,000 in October. The board has since authorized additional repurchases under its existing program, and the company said $15.8 million is available. Dividends paid in the first nine months totaled $1.7 million, compared with $6.9 million in the same period last year.

Natural Health Trends, based in Los Angeles and listed on the Nasdaq under the ticker NHTC, sells personal care, wellness and "quality of life" products through independent members in Asia, the Americas and Europe. Management scheduled a conference call for October 28 at 11:30 a.m. Eastern Time to discuss the results.

Amway India Plans More Store Openings and Revamps Over Next Three to Four Years as CEO Opens Gurugram Center

Tue, 27 Oct 2026 08:00:00 GMT

NEW DELHI, India - October 27, 2026

Amway India is expanding its network of physical stores, with plans to open or revamp several more locations over the next three to four years as part of a multi-year push to give its distributors more face-to-face space to meet customers.

The latest step came during an official visit to India by Michael Nelson, President and CEO of Amway, who opened a new Experience Center in Gurugram. The company said the store rollout builds on the INR 100 crore investment Nelson announced last year for a range of initiatives in India, including a larger physical presence.

Amway India currently operates more than 85 stores nationwide. In recent months it has opened or revamped more than 14 of them in markets including Pune, Kolkata, Siliguri, Imphal, Bhagalpur, Anand, Ahmedabad, Bongaigaon, Agra and Nanded, a mix the company said is meant to balance growth across major metros and tier-2 and tier-3 cities. Its Imphal store was among those upgraded.

Managing Director Rajneesh Chopra said the locations are not conventional retail stores but "engagement hubs" where consumers can try Amway products and distributors can meet customers and build local communities. Chopra said the company has spent the past year adding new stores and converting existing ones to the new format, and intends to keep expanding the footprint across the country.

Nelson called India central to Amway's global growth and said Indian consumers are increasingly looking for science-backed health and wellbeing products, more personalized service and greater convenience. He described the Gurugram opening as a milestone that reflects the company's long-term confidence in the market.

Amway did not say how many new or revamped stores the next phase will include, which cities are planned, or how much of the INR 100 crore investment is earmarked for retail.

The company tied the stores to its compliance message as well, saying it operates under applicable laws and regulations and continues to strengthen governance and business practices, with the physical centers offering a transparent setting for product discovery, consumer education and interaction between consumers and distributors. Direct sellers in India operate under the Consumer Protection (Direct Selling) Rules, 2021.

Amway India is a wholly owned subsidiary of Amway Corporation, part of Alticor Global Holdings Inc. of Ada, Michigan. The company is approaching 30 years in India, where it sells close to 140 products across nutrition, beauty, personal care, home care and consumer durables through its direct selling partners, and operates a manufacturing facility at Nilakotai in Tamil Nadu's Dindigul district. Globally, Amway reports annual revenue of USD 7.3 billion.

Medifast Q3 Revenue Falls 19.4% to $72 Million as Active Optavia/Trilivy Coaches Drop 48% to 10,200

Mon, 26 Oct 2026 08:00:00 GMT

BALTIMORE, Maryland - October 26, 2026

Medifast, Inc., the publicly traded parent of the coach-based nutrition business formerly marketed as Optavia and rebranded as Trilivy in July, reported on October 26, 2026 that third-quarter revenue fell 19.4% to $72.0 million as its field of independent coaches nearly halved over the past year. The company also posted a net loss of $17.5 million, or $1.57 per share, for the quarter ended September 30, 2026, driven largely by restructuring charges.

The number of active earning coaches dropped 47.7% to 10,200, down from 19,500 in the third quarter of 2025. Medifast attributed the decline to continued difficulty acquiring new clients amid a tougher operating environment, including the rapid adoption of GLP-1 weight-loss medications, and said it expects the coach count to keep falling through the end of 2026.

Because the shrinking field was concentrated among less productive coaches, average revenue per active earning coach rose 54.1% to $7,064, compared with $4,585 a year earlier. Chief Executive Officer Nick Johnson said coach productivity has now improved year over year for four consecutive quarters, an indicator he said has historically come before a return to coach and revenue growth.

The quarter marked the main execution phase of a cost-cutting program the company calls Catalyst. Its restructuring component shrinks and relocates parts of Medifast's distribution network, streamlines internal software and realigns staffing to current revenue levels. Catalyst restructuring charges added about $13.8 million to selling, general and administrative expenses, which rose 4.8% to $69.4 million, or 96.3% of revenue. Excluding those charges, adjusted SG&A fell 16.0% to $55.6 million. Coach compensation dropped $6.6 million on lower volume and fewer active coaches.

Gross profit fell 19.5% to $50.0 million, while gross margin held at 69.5%. Loss from operations widened to $19.4 million from $4.1 million a year earlier. On an adjusted basis that excludes Catalyst costs and other items, Medifast reported a net loss of $2.1 million, or $0.19 per diluted share, and adjusted EBITDA of $0.4 million. The company ended the quarter with $172.5 million in cash, cash equivalents and investment securities and no debt.

Johnson said the major pieces of the company's "3.0" strategy are now in the market, including the Trilivy brand and metabolic health system, a new Reset Fuelings product line, a revised coach compensation plan and a new Coach Hub tool. "With enthusiasm high in the Field, we believe we are on track to deliver profitability in the fourth quarter," he said.

For the fourth quarter of 2026, Medifast guided revenue of $55 million to $75 million and earnings of $0.00 to $0.25 per share. For the full year, it expects revenue of $280 million to $300 million and a loss of $1.80 to $2.05 per share, or an adjusted loss of $0.45 to $0.70 per share.

Medifast rebranded its Optavia lifestyle business as Trilivy on July 17, 2026, shifting its pitch from weight loss toward what it describes as a three-phase metabolic health system. The company's coaches, who sell its meal replacements and programs while recruiting and supporting clients, remain the core of its direct sales model, and the latest results show how closely the company's revenue continues to track the size of that coach network.

Sunrun to Pay Connecticut $300,000 and Provide Uncapped Relief in Settlement Over Forged Solar Contracts

Fri, 23 Oct 2026 08:00:00 GMT

HARTFORD, Connecticut - October 23, 2026

Sunrun Inc. will pay $300,000 to the state of Connecticut and must investigate and compensate homeowners who say they were signed into solar contracts through fraud, under a settlement announced October 23 by Connecticut Attorney General William Tong.

The settlement resolves a lawsuit Tong filed in July 2024 against Sunrun, Sunrun Installation Services, Elevate Solar Solutions, Bright Planet Solar and two salespeople, Dakota Grumet and Sierra Howes. The state alleged violations of the Connecticut Unfair Trade Practices Act and the Home Improvement Act, including locking consumers into long-term solar contracts without their consent by impersonating them, forging signatures, performing work without permits and installing systems that did not work. Sunrun contracted with Bright Planet for solar marketing and sales, and Elevate and the two individuals sold contracts on its behalf.

"We sued SunRun and Elevate following shocking consumer complaints, including forged signatures, impersonations of consumers, non-permitted work, and non-functioning systems," Tong said. "They locked homeowners into long-term contracts without full, informed consent, and failed to deliver what was promised."

Beyond the $300,000 payment, Sunrun must notify every consumer whose contract was solicited by Elevate, Howes, Grumet or anyone associated with them who is believed to have used similar tactics. The company must investigate each fraud claim and give the consumer a response within 60 days. Where fraud is substantiated, Sunrun must offer relief that can include cash payments, account credits, contract cancellation or removal of the system. Consumers who say they never received a copy of their contract, and for whom Sunrun cannot prove delivery, may cancel. Disputes go to an independent arbitrator paid for by Sunrun, and the settlement places no cap on the restitution the company may owe. Affected Connecticut customers can file claims by email at CTSupport@sunrun.com.

Elevate must dissolve under the settlement. Elevate, Grumet and Howes face a $200,000 penalty, suspended after $100,000 is paid, to ensure ongoing compliance. Grumet, a principal and managing member of Elevate, is barred for 10 years from owning any business involved in home solicitation sales, must work under direct company supervision and must keep records of any door-to-door or telephone marketing he does. Howes must surrender her home improvement salesperson registrations and may not apply for a new salesperson or contractor registration for 10 years. The case against Bright Planet, which is no longer represented by counsel, remains pending. None of the defendants admitted liability.

The settlement is part of a broader crackdown on residential solar sales in Connecticut. The attorney general's office has an open investigation into SunStrong Management, reached a $100,000 settlement with solar servicer Spruce Power 3 earlier this year, and obtained a $5 million stipulated judgment against Vision Solar in 2024 over high-pressure sales tactics.

Sunrun, based in San Francisco, is the largest residential solar and battery storage provider in the United States and sells many of its systems through door-to-door and dealer sales channels. The company is scheduled to report third-quarter 2026 results after the market closes on November 4. No public response from Sunrun to the settlement had been found as of November 2.

Amway Expands Linus Pauling Institute Research Partnership Into Metabolic Health, Cognition and Antioxidants

Fri, 23 Oct 2026 08:00:00 GMT

ADA, Michigan - October 23, 2026

Amway is widening its research relationship with the Linus Pauling Institute at Oregon State University, adding metabolic health, cognition and the role of antioxidants in cellular health to a collaboration that until now has centered on gut health and healthy aging, the Ada, Michigan-based direct seller announced Thursday.

The expanded agreement marks the second phase of a partnership that began in 2021, when Amway established the Amway Healthspan Fund at the institute. The fund was set up to support work on how gut health and the microbiome affect healthspan, a term researchers use for the number of years a person is able to live an active, independent life, as opposed to lifespan alone. Research articles supported through the fund are published on the institute's Micronutrient Information Center, an online database on the roles of vitamins, minerals, phytonutrients and other dietary factors in health. Amway said the portal is one of the most visited sites at Oregon State University, with more than 1.5 million users from nearly every country.

In 2025, Amway helped fund a study by the institute on the role gut health plays in healthy aging. That research was later published in a peer-reviewed nutrition journal, according to the company.

The new phase moves the collaboration into three additional areas that Amway described as critical to healthspan: metabolic health, cognitive health, and how antioxidants function at the cellular level. The company did not disclose the size of its funding commitment, the length of the new phase, or whether the work is tied to specific products in its Nutrilite supplement line, which is the company's top-selling brand.

Sudhir Baswan, PhD, a senior open innovation scientist at Amway, said the institute is internationally recognized for its work on phytonutrients and human health, and that the expanded effort is intended to deepen scientific understanding of how plant-based compounds, dietary patterns and overall nutrition influence healthspan. The institute is named for Linus Pauling, the chemist who remains the only person to have received two unshared Nobel Prizes, for Chemistry in 1954 and for Peace in 1962.

The relationship between the company and the institute runs in both directions. Emily Ho, PhD, the institute's endowed chair and director and a distinguished professor in Oregon State's College of Health, also sits on Amway's Scientific Advisory Board. Ho, whose research focuses on personalized nutrition for healthy aging, said nutrition is central to advancing healthspan because it affects health throughout the body, and that with so much misinformation in circulation, research findings need to be made accessible to the public rather than staying in the lab.

Kristi Pelc, Amway's chief research and development officer, said the expansion strengthens the company's support for the institute's research and demonstrates its focus on healthspan. She added that the work "instills confidence in our Amway Business Owners and their customers around the world."

That last point reflects how direct sellers increasingly use university research ties as part of the story their distributors tell about products. Partnerships of this kind typically fund independent research at the institution rather than clinical testing of a company's own formulas, and Amway's announcement did not describe any product claims arising from the new work.

The announcement comes at a busy time for the company in the United States. Earlier this month a federal judge in Seattle entered Amway's $225 million settlement with the Federal Trade Commission and the state of Washington, which will require sweeping changes to the company's U.S. compensation plan beginning in mid-2027, including a requirement that distributors resell at least 70 percent of the products they buy each month to earn full bonus credit. The settlement addresses earnings and recruiting practices rather than product science, and Thursday's research announcement did not reference it.

Amway, privately held by the DeVos and Van Andel families, sells nutrition, beauty and home products through independent business owners in more than 100 countries and territories. Its leading brands include Nutrilite, Artistry and XS. The company describes itself as the world's largest direct selling business based on 2025 revenue, citing an annual industry ranking.

Npros will continue to follow Amway's research partnerships and its implementation of the FTC order.

Oriflame Sales Drop 23% and Active Members Fall 26% as Company Flags Going-Concern Doubt and Need for New Funding

Fri, 23 Oct 2026 08:00:00 GMT

SCHAFFHAUSEN, Switzerland - October 23, 2026

Oriflame's sales fell by nearly a quarter in the third quarter and its active community of consultants and customers shrank by more than a quarter, and the Swedish-founded beauty company warned in its latest interim report that it expects to need additional funding that has not yet been committed, a situation it said may cast significant doubt on its ability to continue as a going concern.

In its interim management statement for the period ended September 30, 2026, released Friday, Oriflame reported third-quarter sales of �'�97.6 million, down 23 percent from �'�126.0 million a year earlier. Sales fell in every region: 26 percent in Türkiye and Africa, 22 percent in Asia, 19 percent in Europe and the CIS, and 5 percent in Latin America. The company said its decision to stop selling products made at its Polish factory to outside customers took about 4 percentage points off the quarter's sales; excluding that, sales would have fallen about 18 percent.

The size of the field force is at the center of the decline. Oriflame's active community, which counts members who have placed orders in recent sales campaigns, stood at 1.023 million at the end of September, compared with 1.388 million a year earlier, a 26 percent drop. Unit sales fell 25 percent, only partly offset by a 2 percent positive price and mix effect. Regionally, the company cited a smaller sales force and lower activity in Europe and the CIS, lower recruitment and sales force activity across Asia, and weaker activity plus macroeconomic and geopolitical pressures in Türkiye and Africa.

Adjusted EBITDA was a loss of �'�1.5 million, compared with a profit of �'�0.5 million in the third quarter of 2025. Cost cuts were deep but not deep enough to offset the lost sales: selling and marketing expenses fell 25 percent to �'�31.9 million, largely on lower marketing spending, and administrative expenses fell 15.5 percent to �'�33.0 million as restructuring reduced personnel, IT and travel costs. Oriflame recorded another �'�7.7 million in non-recurring costs during the quarter, which it excludes from adjusted figures. Its adjusted net loss for the quarter was �'�19.9 million.

For the first nine months of the year, sales were down 16 percent at �'�338.5 million, adjusted EBITDA was a loss of �'�12.5 million against a small profit a year earlier, and the adjusted net loss reached �'�63.5 million.

Cash remains tight. Oriflame ended September with �'�23.2 million in cash, down from �'�25.7 million at the start of the quarter and �'�69.0 million at the end of 2025. The company generated �'�3.7 million in adjusted cash flow before financing activities in the quarter, helped by reductions of �'�8.3 million in inventory and �'�5.3 million in receivables. It also completed the transfer of its manufacturing operations in India to a buyer that will now supply it under a long-term manufacturing agreement, a deal that brought in �'�5.0 million in cash. Total debt stood at �'�294.6 million, well below the �'�834.1 million of a year earlier following the recapitalization the company completed in December 2025.

In the going-concern note to its interim financial statements, Oriflame's board and management said the group's forecasts indicate that additional funding is expected to be required during the assessment period to maintain sufficient liquidity and meet obligations as they come due, and that such funding had not been committed when the statements were approved. The company listed material uncertainties including its ability to hit its sales and cash-flow forecasts, to secure that funding, and to meet covenant requirements under its revolving credit facility if testing were triggered earlier than expected. It also said that, although a review of prior-period cross-border activities was completed without any assessment being issued, residual uncertainty remains about potential future cash outflows. The board concluded that it was still appropriate to prepare the accounts on a going-concern basis, citing the December 2025 refinancing, existing financing arrangements, potential additional funding sources and management actions.

On strategy, Oriflame said it is moving to a digital-first commercial model, expanding social commerce, testing AI tools for marketing, recruitment and customer engagement, simplifying onboarding and rolling out a new rewards and incentive framework for sellers. The results were presented by Kenneth Benaim Campbell, who was named chief executive officer in August, and Jog Dhody, the company's chief financial and operating officer.

Oriflame was founded in Sweden in 1967 and sells skincare, cosmetics, fragrances, personal care and wellness products through independent Beauty Entrepreneurs in more than 60 markets. Its parent holding company is incorporated in Jersey.

QNET Says It Terminated 141 Distributor Accounts and Reported 158 Cases to Authorities in Anti-Scam Push

Thu, 22 Oct 2026 08:00:00 GMT

KUALA LUMPUR, Malaysia - October 22, 2026

QNET says it has terminated 141 independent distributor accounts for compliance violations since the start of 2025 and has referred 158 cases to law enforcement, as the Malaysia-based direct seller tries to separate its business from scams carried out in its name. The company disclosed the figures during a series of VCON Malaysia 2026 media webinars held for journalists in West Africa in the week of October 20.

The numbers were presented by Cherif Sarr, QNET's Regional General Manager for West and Central Africa. According to Sarr, the 141 terminations cover the period from 2025 through the time of the briefing, and 26 of the closed accounts were linked to facilitating false or fraudulent cross-border movement of people. He said the company had also reported 158 cases to the relevant authorities and had helped more than 3,000 people return to their home countries or reunite with their families.

The figures are the company's own and were not accompanied by a breakdown by country, by the type of violation behind the remaining terminations, or by the outcome of the cases referred to authorities.

Sarr also described a new Business 2U accreditation process covering distributors who run independent offices under the QNET name. Under the framework, those distributors must go through verification, meet applicable regulatory requirements and receive authorization from the company before opening an office. The process is aimed at the storefront-style offices that have often been at the center of complaints, where people say they were promised jobs, visas or overseas placements in exchange for upfront payments.

The company restated what it calls a zero-tolerance policy toward anyone using its name for scams, fake job offers, coercion or illegal cross-border movement. It urged the public to report suspicious offices and individuals claiming to represent QNET, particularly those asking for money in return for jobs, visa processing or guaranteed returns, and said it would keep working with police, regulators and the media on cases involving misuse of its brand.

QNET pointed to its QNET Against Scams campaign, launched in August 2024, which it says offers public education and channels for reporting suspected fraud. The campaign has run in Ghana, Sierra Leone and Senegal, and the company said it plans to extend it to more countries. QNET also maintains a public compliance portal that sets out its code of conduct, lists prohibited "red line" offenses and publishes lists of terminated distributor IDs by region.

Company representatives used the sessions to restate that QNET distributors earn commissions on product sales rather than recruitment, and that its policies prohibit misleading recruitment practices. The webinars, one held October 20 for journalists from Ghana and another October 22 for journalists from Sierra Leone and Liberia, also reviewed a September trip in which African journalists and social media influencers toured the company's Malaysian headquarters and attended the opening of VCON Malaysia 2026. QNET said it has hosted such visits from several African countries since 2022.

The disclosures come as QNET-linked promoters continue to face enforcement in other markets. In India, where the company has operated through Vihaan Direct Selling, Hyderabad police arrested alleged QNET promoter Dig Vijay Singh at Delhi airport on October 17 as part of a long-running fraud investigation into QNET and Vihaan promoters.

QNET was founded in 1998 as QuestNet and is part of the QI Group, headquartered in Malaysia. It sells wellness, personal care, home and lifestyle products through independent distributors in dozens of countries.

Tupperware Latin America Direct Sales Rise 14% in First Full Quarter Under BeFra as Jafra Slips and Gets Interim Leader

Thu, 22 Oct 2026 08:00:00 GMT

GUADALAJARA, Mexico - October 22, 2026

Tupperware's Latin American direct-selling business delivered its first full quarter under new ownership with double-digit growth in its core channel, according to third-quarter results released Thursday by BeFra, the Mexican group whose legal name is Betterware de México, which bought Tupperware's Mexico and Brazil operations earlier this year. The same report showed sister company Jafra slipping, and BeFra said it has installed its own chief executive as interim head of Jafra Mexico.

BeFra closed the Tupperware Latin America acquisition in June 2026, following Tupperware Brands' 2024 bankruptcy in the United States. In the quarter ended September 30, 2026, the Tupperware brand generated net revenue of 1.376 billion Mexican pesos, or 28.5 percent of BeFra's consolidated revenue. Stripping out business-to-business sales and sales in Argentina and the United States, which BeFra does not count as part of the core direct-selling channel, Tupperware's direct-selling revenue rose 14.0 percent from the same period a year earlier on a combined basis, to 1.352 billion pesos.

Mexico led the gain. BeFra said Tupperware Mexico's direct-selling business grew 23.0 percent year over year, while the decline at Tupperware Brazil narrowed to 3.3 percent, compared with drops of 10 to 15 percent before the acquisition. Total brand revenue still fell 6.8 percent on a combined basis because the prior-year quarter included large one-time sales through channels outside direct selling that BeFra discontinued after the deal. Tupperware ended the quarter with 252,704 associates, a figure that counts sellers, distributors, unit managers and leaders, and averaged 278,778 over the period.

Profitability at Tupperware was lower than a year ago. The brand produced EBITDA of 359 million pesos, a 26.1 percent margin, against 31.1 percent in the third quarter of 2025 on a combined basis. BeFra attributed the decline to spending on revitalizing the brand and to weaker fixed-cost absorption after the non-direct sales went away, and said a margin in the mid-20s is the level it expects going forward. Tupperware accounted for 35.6 percent of group EBITDA in the quarter.

Jafra moved the other way. The beauty and personal care company, which BeFra acquired in 2022, posted third-quarter revenue of 1.934 billion pesos, down 2.8 percent, and EBITDA fell 20.1 percent to 327 million pesos. BeFra blamed a difficult summer holiday period in Mexico and shifts in consumer attention during the World Cup, and said Jafra, unlike Betterware, could not make up the difference through higher seller productivity. After what it described as several quarters of inconsistent growth and a slower-than-planned rollout of changes to align Jafra with the group's commercial model, BeFra appointed President and CEO Andrés Campos Chevallier as interim managing director of Jafra Mexico. The company said the interim period is expected to last six to twelve months while Campos helps identify a permanent successor. BeFra also said Jafra's U.S. business posted another quarter of positive EBITDA under a leaner expense structure.

The Betterware home-goods brand grew revenue 9.7 percent to 1.523 billion pesos, its third straight quarter of year-over-year growth, although freight costs tied to supply-chain disruptions in the Middle East trimmed its margin.

For the group as a whole, net revenue rose 43.1 percent to a record 4.832 billion pesos, EBITDA increased 39.6 percent to 1.008 billion pesos and net income rose 24.2 percent to 390 million pesos. Organic revenue, which excludes Tupperware, grew 2.3 percent. BeFra's average associate base across all three brands climbed 23.7 percent to about 1.46 million, reflecting the addition of Tupperware's independent sellers. The company generated 1.059 billion pesos in free cash flow, paid down 431 million pesos of debt and lowered its net debt to 1.65 times EBITDA.

BeFra raised its full-year 2026 revenue growth guidance, including Tupperware, to 24 to 26 percent from 18 to 22 percent, while narrowing its organic growth outlook to 4 to 5 percent from 4 to 8 percent. It expects a full-year EBITDA margin of 19 percent. Shareholders approved a quarterly dividend of 250 million pesos, payable in the fourth quarter.

Tupperware was founded in 1946 and built its business on home parties run by independent consultants. BeFra, which trades on the New York Stock Exchange, is based in Guadalajara and now operates Betterware, Jafra and Tupperware across Mexico, Brazil, the United States and other Latin American markets.

Young Living Served With California Prop 65 Notice Alleging Pulegone in Deep Relief Roll-On

Wed, 21 Oct 2026 08:00:00 GMT

BERKELEY, California - October 21, 2026

Young Living Essential Oils has been served with a California Proposition 65 notice alleging that its Deep Relief Essential Oil Roll-On exposes consumers to pulegone without the warning the state's right-to-know law requires.

The 60-day notice of violation, dated October 21, 2026, was sent by Center for Consumer Safety LLC (CCS), a Berkeley-based group that brings private enforcement actions under the Safe Drinking Water and Toxic Enforcement Act of 1986. It names three alleged violators: Young Living Essential Oils, LC, served through its registered agent in Salt Lake City; Epic Global Incorporated of Highland, Utah, which the notice links to the same product listing; and Amazon.com Services LLC. The representative product is Young Living Deep Relief Essential Oil Roll-On, identified by a single Amazon listing number. The notice was uploaded to the California Attorney General's Proposition 65 system on the same day and served on district attorneys and city attorneys across the state.

The notice covers the product category of essential oil roll-ons and lists Deep Relief as a representative example, while stating that it does not extend to unrelated product categories. CCS alleges that ordinary use of the roll-on exposes consumers to pulegone through skin absorption, inhalation and ingestion, and that buyers are not given a clear and reasonable Proposition 65 warning before that exposure. It says the alleged violations began no later than April 3, 2026, and were continuing as of the notice date.

Pulegone is a compound found naturally in certain mint-family plant oils. California added it to the Proposition 65 list of chemicals known to the state to cause cancer in 2014. Proposition 65 does not ban listed chemicals in consumer products; it requires businesses to warn California consumers before knowingly and intentionally exposing them, unless the exposure falls below levels set by state regulators.

CCS says it intends to file a private enforcement lawsuit once the 60-day notice period runs out if the matter has not been resolved and no public prosecutor has taken up the case. The group says it is seeking a binding resolution that would address products already sold, including a recall where appropriate, prevent future unwarned exposures through compliant warnings or reformulation, and impose a civil penalty. Under the statute, civil penalties can reach $2,500 per violation per day. A certificate of merit filed with the notice states that CCS's in-house counsel consulted with people who have relevant expertise and believes there is a reasonable and meritorious case for a private action. CCS also asked the companies to preserve product composition, sourcing, sales, labeling and compliance records.

A Proposition 65 notice is an allegation, not a finding of wrongdoing, and no lawsuit had been filed as of the notice date. The notice does not announce a recall, and it does not claim the roll-on is unsafe at the levels found; it alleges only that the required warning is missing. No public response from Young Living to the notice had been found as of October 27.

Young Living, headquartered in Lehi, Utah, sells essential oils, blends, roll-ons, supplements and personal care products through independent brand partners. Deep Relief is one of its pre-diluted roll-on blends marketed for topical use. The notice follows a separate Proposition 65 notice served on Arbonne International on October 13 over lead and cadmium in its protein shakes.

Former eXp Agents Golden and Bjorkman Settle Sexual Assault Suit Two Days Into Trial, Ending Roberts Case

Wed, 21 Oct 2026 08:00:00 GMT

LOS ANGELES, California - October 21, 2026

Two former eXp Realty agents accused of drugging and sexually assaulting a fellow agent at company recruiting events have reached a confidential settlement with their accuser, ending a federal civil trial in Los Angeles just two days after it began and effectively closing out the lawsuit that put a spotlight on eXp's recruiting culture.

Attorneys for Anya Roberts filed a notice on Wednesday, October 21, in the U.S. District Court for the Central District of California stating that she had reached a settlement with David S. Golden and Michael L. Bjorkman that "fully and finally" resolves all of her claims against the two men. The parties said they expect to file dismissal paperwork within 15 days after the settlement agreement is finalized. Financial terms were not disclosed. Golden and Bjorkman have denied the allegations, and their attorneys did not comment publicly on the deal.

The agreement came three days after Roberts settled with the case's corporate defendants. On Sunday, October 18, one day before trial, she disclosed a confidential settlement in principle with eXp Realty LLC, its parent company AGNT, Inc., formerly known as eXp World Holdings, and founder Glenn Sanford. eXp has said that settlement is not an admission of wrongdoing and that it has consistently denied the claims. With both settlements in place, no defendants remain to be tried in Roberts' case.

Roberts, an eXp agent, filed suit in December 2023. She alleged that Golden and Bjorkman, who were prominent recruiters inside eXp's revenue share system, drugged and sexually assaulted her during company recruiting events in 2020, and that once she would not do everything Golden wanted, including choosing him as her sponsor, he stalled her career. Her complaint also accused eXp and its leadership of knowingly benefiting from the two men's recruiting production while ignoring complaints about their conduct.

In August, U.S. District Judge André Birotte Jr. split the case into two trials. The first, against Golden and Bjorkman alone, opened Monday, October 19. The second, against eXp Realty, AGNT and Sanford, had been set for November 16 before the company settled. Some claims against AGNT and Sanford, including sex trafficking, vicarious liability and negligent hiring theories, had already been dropped in August, though eXp Realty itself still faced them until the October 18 agreement.

The brief trial was contentious. Hundreds of pages of explicit text messages were put before the court, and the judge ordered the defense to pare down more than 230 pages of intimate messages it wanted to use and voiced frustration over the volume of last-minute filings. By the second day the courtroom had been temporarily closed to the public. The settlement was announced the following day.

"We are very pleased to have reached a resolution that allows our client to put this litigation behind her and move forward with the next chapter of her life," attorneys for Roberts said in a statement.

The settlements do not end the legal fallout. A related federal case known as Acevedo, filed in February 2023 by four women who accuse Golden and Bjorkman of using eXp recruiting events and promises of career help to lure and drug them, remains pending before the same judge, with eXp Realty, AGNT and Sanford among the defendants. That case is scheduled for trial in March 2028. Andrea Hirsch, an attorney for the plaintiffs in both cases, said that while Roberts has resolved her claims, four other women are still waiting for their day in court and the legal team's focus now turns to that case.

eXp also faces separate retaliation suits. Top agent Noelle Nielsen, who gave a detailed account of the two men's alleged misconduct at company events, has an ongoing case against eXp and Sanford in Minnesota state court, and former employee Ashley Golladay sued eXp in Washington state court after reporting harassment by another executive. A shareholder derivative suit in Delaware accusing Sanford and other directors of ignoring sexual misconduct has also been allowed to proceed.

Bjorkman was arrested in Las Vegas in 2021 and charged with two counts of sexual assault, but prosecutors later dropped the criminal case, saying they could not prove the allegations beyond a reasonable doubt.

The court activity comes during a period of transition at the top of the company. Sanford stepped down as chief executive of AGNT in early October and was succeeded by Leo Pareja, who had led eXp Realty since 2024. Sanford remains chairman of the board.

eXp Realty is a cloud-based residential real estate brokerage that pays agents revenue share for recruiting other agents, a structure that has drawn comparisons to network marketing. Its parent, AGNT, Inc., trades on Nasdaq.

Npros will continue to follow the Acevedo case and eXp's other pending litigation.

American Income Life Agent Count Falls 7% in Third Quarter as Life Sales Stay Flat, Globe Life Results Show

Wed, 21 Oct 2026 08:00:00 GMT

McKINNEY, Texas - October 21, 2026

American Income Life's sales force shrank in the third quarter, according to results released Wednesday by parent company Globe Life Inc. The division, which sells life and supplemental health insurance through its own exclusive agents, averaged 11,331 producing agents in the quarter ended September 30, 2026, down 7 percent from 12,230 a year earlier and down 60 agents from 11,391 in the second quarter.

The smaller agent force showed up in new business. American Income's life net sales, which Globe Life calculates as annualized premium issued minus policies canceled in the first 30 days, came to $96.6 million, essentially flat against $96.5 million in the third quarter of 2025. Health net sales at the division fell 16 percent to $3.9 million from $4.6 million.

The policies already on the books continued to grow. American Income's life premium rose 4 percent to $470.4 million from $451.2 million, and its life underwriting margin, a measure of premium left after claims, commissions and acquisition costs, increased 3 percent to $268.5 million, or 57 percent of premium compared with 58 percent a year earlier. Health premium at the division slipped 1 percent to $31.5 million, while its health underwriting margin jumped to $37.9 million from $14.8 million. Globe Life said that jump was driven mainly by annual assumption updates; excluding those updates, the division's health margin was 65.4 percent of premium versus 59.7 percent a year ago.

American Income remains Globe Life's largest life insurance channel, accounting for more than half of the company's $864.6 million in third-quarter life premium and about 65 percent of its $149.1 million in total life net sales. By comparison, the Liberty National Division grew its average producing agent count 9 percent to 4,187 and its life net sales 7 percent, while the Family Heritage Division held roughly steady at 1,565 agents.

For Globe Life as a whole, third-quarter net income was $361.1 million, or $4.62 per diluted share, compared with $387.8 million, or $4.73 per diluted share, a year earlier. Net operating income, a non-GAAP measure the company uses to track its core business, was $4.84 per diluted share versus $4.81. Total premium revenue grew 7 percent.

The company trimmed its full-year 2026 guidance for net operating income to a range of $15.35 to $15.65 per share. Globe Life attributed the change to two items at its United American General Agency division rather than its core business: high-severity claims at Evry, a group health business it is still building, and a claims processing delay at the Centers for Medicare and Medicaid Services that produced about $7 million in excess prior-period Medicare Supplement claims during the quarter. For 2027, the company projected net operating income of $16.10 to $17.10 per share.

Globe Life repurchased 1.1 million shares during the quarter for $185 million and now expects to spend $725 million to $775 million on buybacks for the full year, up from previous guidance of $670 million to $700 million. Management was scheduled to discuss the results with analysts on a conference call on October 22.

American Income Life Insurance Company was founded in 1951 by Harold Goodman and his nephew, Bernard Rapoport, and is based in Waco, Texas. It recruits and trains its own agents, who sell life and supplemental health coverage to working families, including members of labor unions, credit unions and associations. Globe Life, headquartered in McKinney, Texas, reports the business as its American Income Life Division, and the division's producing agent count is one of the figures the company highlights each quarter as a gauge of future sales.

Korea Fair Trade Commission Opens First-Ever Direct Sales Consent Decision Process for Unicity Korea Over Bonus Cap Allegations

Wed, 21 Oct 2026 08:00:00 GMT

SEJONG, South Korea - October 21, 2026

South Korea's Fair Trade Commission has opened consent decision proceedings for Unicity Korea, the Korean arm of Utah-based network marketing company Unicity International, over allegations that the company sidestepped the country's legal cap on distributor commissions by having its U.S. headquarters pay bonuses to top Korean distributors. It is the first time the regulator has started the consent decision process since the tool was added to Korea's Door-to-Door Sales Act.

The commission announced the decision Wednesday, October 21. Under a consent decision, a company under investigation proposes its own corrective and remedial measures, and if the commission accepts them, the case is closed without a formal ruling on whether the law was broken and without a penalty surcharge. The commission stressed that opening the procedure is neither a finding that Unicity Korea violated the law nor final approval of a settlement.

At the center of the case is Article 20, Paragraph 3 of the Door-to-Door Sales Act, which limits the total support bonuses a multi-level marketer may pay its distributors to 35 percent of the sales of goods supplied to those distributors. Investigators had been examining whether Unicity Korea moved the affiliation of some of its highest-ranking distributors to Unicity International in the United States, which then paid their commissions directly. If the bonuses paid by the U.S. parent are counted as Unicity Korea's own, the Korean company would have exceeded the statutory ceiling in every year from 2021 through 2024.

The legal question had not gone the regulator's way elsewhere. A civil appellate court that examined the same facts in a related case ruled that the U.S. headquarters' payments could not be treated as a scheme to help Unicity Korea evade the cap, and prosecutors declined to bring charges on the same grounds. Rather than continue contesting the issue, Unicity Korea applied for a consent decision, saying it would build a compliance framework for its bonus payout ratio and work more closely with its distributors and customers.

The company's proposed corrective measures include re-registering the distributors now enrolled under the U.S. headquarters as Unicity Korea distributors, adjusting the point value and prices of key products so that the bonus payout ratio stays within the legal limit, and forming a committee to monitor bonus payments. Unicity Korea also proposed consumer protection and distributor support steps: extending its product return period from 20 days to three months, providing compliance training to distributors and regional customer support centers, strengthening its distributor counseling center, posting information on how to avoid illegal multi-level marketing schemes on its website three days each month, and upgrading its IT systems.

The commission said the proposals meet the preliminary requirements to begin the procedure. Next, it will work with Unicity Korea on a provisional consent decision, which by law must be opened to stakeholders for comment for at least 30 days, and will consult with other relevant agencies. The final plan will then go to the full commission, which will decide whether to approve it. If approved, failure to carry out the agreed measures without good reason can lead to penalties.

The consent decision mechanism was written into the Door-to-Door Sales Act by an amendment passed in January 2022 and took effect in July of that year. Unicity Korea's case is the first to reach this stage, making it a test of how Korea will use negotiated remedies rather than fines in disputes over how multi-level marketers structure compensation across borders.

Unicity International is headquartered in Orem, Utah, and sells nutritional supplements and health products through independent distributors in dozens of markets, with South Korea among its significant Asian operations. The allegations have not been proven, and the commission has not ruled on whether any law was violated.

eXp Realty, AGNT and Glenn Sanford Settle Agent's Sexual Assault Suit as Trial of Two Former Agents Opens

Mon, 19 Oct 2026 08:00:00 GMT

LOS ANGELES, California - October 19, 2026

eXp Realty, its parent company AGNT, Inc., and founder Glenn Sanford have reached a confidential settlement with Anya Roberts, the eXp agent whose federal lawsuit accused two former eXp agents of drugging and sexually assaulting her at company recruiting events and claimed the brokerage and Sanford knowingly benefited from that conduct. The agreement removes the corporate defendants from the case less than a month before they were scheduled to face a jury.

Roberts disclosed the agreement in a one-page partial dismissal filed Sunday, October 18, in the U.S. District Court for the Central District of California, one day before the first of two scheduled trials was set to begin. The filing states that Roberts and eXp Realty LLC have reached a confidential settlement in principle that will fully and finally resolve all of her claims against eXp Realty, Sanford, and AGNT, formerly known as eXp World Holdings. It adds that the settlement concerns the eXp defendants only and that Roberts intends to keep litigating against the other defendants. Dismissal papers are expected within 15 days once the settlement agreement is finalized. The terms were not disclosed.

In a statement, an eXp spokesperson said the company and Roberts were pleased to have resolved the lawsuit, that eXp has consistently denied the claims, and that the resolution is not an admission of wrongdoing. The company said Roberts has remained an eXp agent throughout the litigation and expects to stay affiliated with the brokerage, and that eXp is committed to an agent community where every agent is safe, respected, and heard.

Roberts filed suit in December 2023. She alleged that then-eXp agents David Golden and Michael Bjorkman drugged and sexually assaulted her at eXp recruiting events in February and March 2020, and that eXp Realty and Sanford knowingly benefited from what she described as sex trafficking by the two men. Golden and Bjorkman, who are no longer affiliated with eXp, have denied the allegations. The case, Roberts v. eXp Realty, LLC, No. 2:23-cv-10492, is before U.S. District Judge André Birotte Jr.

In August, Judge Birotte split Roberts' claims into two jury trials and narrowed the case against the corporate defendants. His August 20 order released AGNT from all of Roberts' claims and granted Sanford summary judgment on vicarious liability and on negligent hiring, supervision and retention. That left Sanford and eXp Realty facing beneficiary liability claims under the federal Trafficking Victims Protection Reauthorization Act, with eXp Realty also facing vicarious liability and negligent hiring, supervision and retention claims. Those claims were to be tried beginning November 16. The settlement resolves them.

The first trial, against Golden and Bjorkman alone, opened Monday, October 19, at the federal courthouse in Los Angeles. Jurors will consider Roberts' claims of sexual battery, civil battery and intentional infliction of emotional distress tied to events on or about March 10 to 13, 2020, in Florida. Roberts had earlier voluntarily dropped sex trafficking claims against the two former agents. The plaintiff estimated the trial would last five or six court days over the weeks of October 19 and October 26. Roberts settled separately in January 2026 with Brent Gove, the eXp team leader who hosted the recruiting events.

The settlement does not end eXp's exposure to the allegations. A related federal case known as Acevedo, brought in early 2023 by several plaintiffs who made similar accusations against Golden and Bjorkman and who allege the company and Sanford turned a blind eye because of the recruiting income the two men generated through eXp's revenue share program, remains pending before the same judge, with eXp Realty, AGNT and Sanford among the defendants. The same law firms represent the plaintiffs in both cases. A shareholder derivative suit in Delaware accusing Sanford and other directors of ignoring sexual misconduct has also been allowed to proceed.

The settlement comes weeks after a leadership change at the top of the company. Sanford stepped down as chief executive of AGNT earlier in October and was succeeded by Leo Pareja; Sanford remains chairman of the board.

Hyderabad Police Arrest QNET Promoter Dig Vijay Singh at Delhi Airport in Alleged Rs 10,000 Crore Fraud Probe

Sat, 17 Oct 2026 08:00:00 GMT

HYDERABAD, India - October 17, 2026

Police in Hyderabad have arrested a senior QNET promoter at New Delhi's international airport as he was allegedly trying to leave India for Dubai, the latest arrest in a long-running Indian investigation into the multi-level marketing company and its Indian affiliate, Vihaan Direct Selling (India) Pvt. Ltd.

The Central Crime Station of the Hyderabad City Police Detective Department said Saturday, October 17, that it had taken Dig Vijay Singh, 50, into custody at Indira Gandhi International Airport after he was stopped there under a Look Out Circular issued by Hyderabad police. Singh, a resident of Gurugram and a native of Madhya Pradesh, is listed as accused number 11 in the case. Police said a special team took custody of him at the airport police station and seized two mobile phones. He was produced before a court in Delhi, which granted transit remand so he could be brought before the court in Hyderabad, and investigators said they would seek police custody to question him about his role, his financial transactions and the activities of other accused.

According to Hyderabad Police Commissioner V. C. Sajjanar, Singh is a "V-Partner" and key member of the QNET network who is suspected of operating from Dubai with a global base of associates. Police allege he promoted QNET through Zoom meetings and social media, persuading people to invest lakhs of rupees. Investigators allege that promoters and associates of QNET and Vihaan Direct Selling lured the public with promises of high returns, commissions and foreign trips under the guise of multi-level marketing, binary business models and e-commerce activity.

In the cases handled by the Central Crime Station, police said 43 victims have been examined so far, with losses of roughly �'�5 crore, and a bank account belonging to Vihaan Direct Selling (India) Pvt. Ltd. holding about �'�4 crore has been frozen. Police said investigations across multiple cases around the country suggest the alleged fraud could total nearly �'�10,000 crore and affect lakhs of people. That figure is a police estimate, and actual losses and individual responsibility have yet to be established in court. Investigators said they are also examining an international dimension, including promotional programs held in India and abroad, the possible involvement of foreign nationals, and whether operations were coordinated from Dubai. Efforts are under way to trace other accused who are absconding.

The Hyderabad case has been registered under Sections 318(4), 316(2) and 61(2) of the Bharatiya Nyaya Sanhita, covering cheating, criminal breach of trust and criminal conspiracy, along with Section 5 of the Telangana Protection of Depositors of Financial Establishments Act and Sections 3, 4, 5 and 6 of the Prize Chits and Money Circulation Schemes (Banning) Act, India's main law against pyramid-style money circulation schemes.

The arrest adds to years of enforcement action against QNET-linked promoters in India. Hyderabad police arrested 32 QNET promoters in March 2026, the same month three promoters were sentenced to ten years in prison in Andhra Pradesh, and five promoters were arrested in Goa in July 2026. India's Central Bureau of Investigation separately took up a case in September after a debt-related suicide in Telangana's Siddipet district was linked to QNET, and the Telangana High Court has since granted interim protection from coercive action to two directors named in that case. Earlier actions include the 2019 shutdown of Vihaan Direct Selling's operations by the Union Ministry of Corporate Affairs and the freezing of bank funds tied to QNET in 2023 cases.

QNET was founded in 1998 as QuestNet and is part of the Malaysia-based QI Group co-founded by Vijay Eswaran. It sells wellness, personal care, home and lifestyle products through independent representatives in dozens of countries. In India it has operated through Vihaan Direct Selling and other names, and the company has said in past disputes that it complies with local laws and is not responsible for the conduct of people who misuse its name. The allegations against Singh have not been tested in court.

Mannatech Says It Has Regained Nasdaq Equity Compliance After Restructuring Swiss Subsidiary Ownership

Wed, 14 Oct 2026 08:00:00 GMT

FLOWER MOUND, Texas - October 14, 2026

Mannatech, Incorporated says it believes it has regained compliance with the Nasdaq Capital Market's minimum stockholders' equity requirement, three days before the end of the 180-day cure period it had asked for, after reorganizing how the company owns its Swiss holding subsidiary.

In a Form 8-K filed October 14, 2026, the Flower Mound-based network marketing company said that after its third quarter ended on September 30, it entered into a share purchase agreement under which Mannatech, Incorporated now owns 100 percent of Mannatech Swiss Holdings GmbH directly. The Swiss unit had previously been held indirectly through Mannatech (Gibraltar) Holdings Limited.

According to the filing, a ruling from the Swiss Federal Tax Administration confirms that the new direct ownership qualifies distributions from Swiss Holdings for a reduced 5 percent withholding tax rate under Article 10(2)(a) of the income tax treaty between the United States and Switzerland. That rate replaces the higher withholding rates that previously applied to certain of Mannatech's foreign unremitted earnings. Management then reassessed, jurisdiction by jurisdiction, the deferred tax liability the company carries on those earnings and applied that reassessment, on a pro forma basis, to the stockholders' equity it reported at June 30, 2026. On that basis, Mannatech said, it believes it now meets the rule. The filing does not state a pro forma equity figure.

Nasdaq Listing Rule 5550(b)(1) requires companies on the Capital Market to maintain at least $2.5 million in stockholders' equity. Nasdaq's Listing Qualifications Department notified Mannatech on April 20, 2026, that it had fallen below that level. The company's 2025 annual report showed stockholders' equity of negative $5,223,000 at December 31, 2025, and its most recent quarterly report showed negative $4,970,000 at June 30, 2026. Mannatech submitted a plan to regain compliance on June 4 and asked for the full 180 calendar days to show compliance, a period that, if granted, ran through October 17, 2026. At Nasdaq's request, the company also provided monthly balance sheet and income statement projections for the following 12 months in July.

The company was careful to describe the result as management's current assessment. The pro forma adjustment will be reviewed by Mannatech's independent registered public accounting firm as part of the quarterly report for the period ending September 30, 2026, which the company expects to file on or before November 16, 2026. Mannatech said there can be no assurance that Nasdaq will agree with its assessment, that it will regain or maintain compliance, or that its common stock will remain listed on the Nasdaq Capital Market.

Nasdaq has told the company it will keep monitoring its stockholders' equity. If Mannatech does not show compliance when it files its annual report for the year ending December 31, 2026, it may be subject to delisting, though it would have the right to appeal any such determination to a Nasdaq Hearings Panel. The filing was signed by Chief Financial Officer Yasir Haider.

The listing issue capped a difficult stretch for the company. In April, Mannatech filed a notice that its 2025 annual report would be late, saying its independent auditor had raised the possibility of a going concern issue. Results have since steadied. The company reported first-quarter 2026 net income of $1.0 million on net sales of $24.9 million, and second-quarter net income of $1.0 million on net sales of $26.7 million, with income from operations of $1.0 million compared with an operating loss a year earlier.

Leadership has also changed over the same period. Yasir Haider, who had been serving as interim chief financial officer, was named to the role permanently in June. Longtime chairman J. Stanley Fredrick retired from the board effective September 1, and Robert Toth became chairman. Landen Fredrick remains chief executive officer.

For Mannatech's independent associates and shareholders, the immediate takeaway is that the company believes it has cleared the equity hurdle that put its listing at risk, without raising new capital. Final confirmation depends on the auditor's review and on Nasdaq. Mannatech's common stock continues to trade on the Nasdaq Capital Market under the symbol MTEX.

Founded in 1993, Mannatech develops and sells nutritional supplements, skin care and anti-aging products, and weight-management products through independent associates in the Americas, Europe, the Middle East and Africa, and the Asia-Pacific region.